Medical Weight Loss for Carson City, Nevada Residents

Carson City, Nevada residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving Carson City through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

Open to all of Nevada, including Carson City: our Costa Mesa, California physicians treat patients statewide by telehealth, so distance from our office never changes the care you receive. Doctor review just $119 (medication separate).

Why Carson City Residents Choose New Hope Weight Loss

New Hope was designed around the way Carson City residents actually live. You book your physician visit online, meet Dr. Anjmun Sharma by video, and if treatment makes sense your medication ships to your door. Everything runs through our Costa Mesa clinic by telehealth, so there is no local office to visit and no day off work required. The convenience is real, but the medical care behind it is the part we protect most.

Carson City is part of the area New Hope Weight Loss serves by telehealth. The same compounded semaglutide and tirzepatide protocols, the same flat pricing, and the same bilingual support reach Carson City patients at home.

You do not need a clinic on your street in Carson City to work with a real physician, because everything Dr. Sharma offers from Costa Mesa reaches patients across Nevada by secure telehealth. We care for patients throughout the greater Carson City area and the capital region. Every prescription is reviewed and authorized by Dr. Anjmun Sharma, MD, before anything is sent to your address in Nevada.

By handling visits through telehealth, we serve every neighborhood in Carson City, from the greater Carson City area and the capital region, without asking anyone to travel. The 90-day semaglutide program is $499, which works out to a lower monthly cost than paying month to month for many Carson City patients. Nevada is one of the fastest-growing states in the West, and New Hope Weight Loss cares for patients across it entirely by telehealth from our Costa Mesa, California clinic.

GLP-1 Weight Loss Programs Available

Which GLP-1 program is right for you?

Our 90-Day Metabolic Reset runs on semaglutide, the same active ingredient as Wegovy and Ozempic. It starts at $166 a month, or $499 for 90 days, and branded-drug trials reported average loss near 15 to 17 percent. Because compounded semaglutide is not FDA-approved or brand-identical, results vary. Dr. Sharma guides every Carson City patient by telehealth.

And if you want more horsepower

Tirzepatide, from $233 a month, adds GIP to the usual GLP-1 action. In branded-drug trials, dose-qualified participants reached up to 22.5 percent loss, which is not the typical outcome. It shares its active ingredient with Mounjaro and Zepbound.

A $119 physician review starts the process. Medication billed separately. HSA, FSA, Klarna, and Affirm accepted.

How Telehealth Works for Carson City

Starting care with us looks nothing like a traditional doctor visit. There is no office to find and no drive across Carson City. You complete an online intake quiz covering your health background and weight goals, and Dr. Anjmun Sharma reviews it personally. She then meets you by secure video, typically within 48 hours, to decide together whether compounded semaglutide or tirzepatide is appropriate. If it is, a state-licensed 503(a) pharmacy ships your medication to your Carson City address in cold-pack packaging that protects it in transit, and all of your follow-ups happen by video so your plan keeps moving wherever you are in .

Frequently Asked Questions, Carson City

Is there a New Hope Weight Loss clinic near Carson City?

Our physical clinic is in Costa Mesa, California, and we care for patients in Carson City, Nevada entirely by telehealth. You do not need a local office to start. Dr. Anjmun Sharma reviews your history and goals during a secure video consult, and your eligibility for a compounded GLP-1 program is confirmed there.

Do I have to travel to Costa Mesa from Carson City for treatment?

No. Everything happens online, so Carson City patients never drive to California. Your consult, follow-ups, and messaging run through a private portal. If you are approved, compounded semaglutide or tirzepatide ships straight to your Carson City address in temperature-controlled cold-pack packaging to keep it stable in transit.

What does treatment cost for someone in Carson City?

The physician review is $119. Compounded semaglutide starts at $166 a month, or $499 for the 90-day program, and tirzepatide starts at $233 a month. Medication is billed separately. We accept HSA, FSA, Klarna, and Affirm, and there is no distance surcharge for Carson City patients.

What areas of Carson City do you serve?

We serve patients from across Carson City by telehealth, including the greater Carson City area and the capital region.

How does compounded medication compare on cost for Carson City patients?

Compounded semaglutide from $166/month and tirzepatide from $233/month are a fraction of typical brand-name cash prices. Carson City patients see flat pricing up front, and compounded semaglutide and tirzepatide are not FDA-approved or brand-identical, which Dr. Sharma reviews with you.

Carson City Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Carson City, Nevada by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.